This may reflect the capacity of the antisense HERVs to generate dsRNAs [58] that trigger cytosolic sensing and modulate innate immunity, as found in cancer, following IFN-γ exposure [20], or when using methyltransferase inhibitors that lead to a type I interferon response [19]. This evidence concerns the gene IFNG and cancer.